These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 18785045)

  • 1. Design and evaluation of transdermal drug delivery system for curcumin as an anti-inflammatory drug.
    Patel NA; Patel NJ; Patel RP
    Drug Dev Ind Pharm; 2009 Feb; 35(2):234-42. PubMed ID: 18785045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, development, physicochemical, and in vitro and in vivo evaluation of transdermal patches containing diclofenac diethylammonium salt.
    Arora P; Mukherjee B
    J Pharm Sci; 2002 Sep; 91(9):2076-89. PubMed ID: 12210054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system.
    Limpongsa E; Umprayn K
    AAPS PharmSciTech; 2008; 9(2):464-70. PubMed ID: 18431661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal therapeutic system of carvedilol: effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics.
    Ubaidulla U; Reddy MV; Ruckmani K; Ahmad FJ; Khar RK
    AAPS PharmSciTech; 2007 Jan; 8(1):2. PubMed ID: 17408218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, optimization, and evaluation of a transdermal patch of heparin sodium.
    Patel RP; Gaiakwad DR; Patel NA
    Drug Discov Ther; 2014 Aug; 8(4):185-93. PubMed ID: 25262597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation design and in vitro ex vivo evaluation of transdermal patches of Cinnarizine.
    Yamsani VV; Mudulaghar MK; Afreen S; Wajid S; Ravula SK; Babelghaith SD
    Pak J Pharm Sci; 2017 Nov; 30(6):2075-2083. PubMed ID: 29175776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hydrophilic and hydrophobic polymers on permeation of S-amlodipine besylate through intercalated polymeric transdermal matrix: 3(2) designing, optimization and characterization.
    Rastogi V; Yadav P; Husain A; Verma A
    Drug Dev Ind Pharm; 2019 Apr; 45(4):669-682. PubMed ID: 30633579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and evaluation of curcumin gel for topical application.
    Patel NA; Patel NJ; Patel RP
    Pharm Dev Technol; 2009; 14(1):80-9. PubMed ID: 18821270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of matrix-type transdermal delivery of lornoxicam: in vitro evaluation and pharmacodynamic and pharmacokinetic studies in albino rats.
    Baviskar DT; Parik VB; Jain DJ
    PDA J Pharm Sci Technol; 2013; 67(1):9-22. PubMed ID: 23385560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled systemic delivery of indomethacin using membrane-moderated, cream formulation-based transdermal devices.
    Rao PR; Chalasani KB; Chauhan AS; Jain AK; Diwan PV; Ram MK
    Drug Deliv; 2006; 13(3):207-13. PubMed ID: 16556573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies.
    Yener G; Üner M; Gönüllü Ü; Yildirim S; Kiliç P; Aslan SS; Barla A
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1466-73. PubMed ID: 21048338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
    Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
    AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
    Tirunagari M; Jangala VR; Khagga M; Gannu R
    Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    Curr Drug Deliv; 2007 Jan; 4(1):69-76. PubMed ID: 17269919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride.
    Kusum Devi V; Saisivam S; Maria GR; Deepti PU
    Drug Dev Ind Pharm; 2003 May; 29(5):495-503. PubMed ID: 12779279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the Component Excipients on the Quality and Functionality of a Transdermal Film Formulation.
    Saoji SD; Atram SC; Dhore PW; Deole PS; Raut NA; Dave VS
    AAPS PharmSciTech; 2015 Dec; 16(6):1344-56. PubMed ID: 25922089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin nanoemulsion for transdermal application: formulation and evaluation.
    Rachmawati H; Budiputra DK; Mauludin R
    Drug Dev Ind Pharm; 2015 Apr; 41(4):560-6. PubMed ID: 24502271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal atenolol releasing system: an approach towards its development.
    Gupta SP; Jain SK
    J Drug Target; 2006 Nov; 14(9):607-13. PubMed ID: 17090396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.